Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Pneumonia Vaccine Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Pneumococcal Conjugate Vaccine (PCV13)
  • 1.3.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
• 1.4 Market Segment by Application
  • 1.4.1 Global Pneumonia Vaccine Market Share by Application (2019-2025)
  • 1.4.2 Pneumonia
  • 1.4.3 Meningitis
  • 1.4.4 Sepsis
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Pneumonia Vaccine Market Size
  • 2.1.1 Global Pneumonia Vaccine Revenue 2014-2025
  • 2.1.2 Global Pneumonia Vaccine Sales 2014-2025
• 2.2 Pneumonia Vaccine Growth Rate by Regions
  • 2.2.1 Global Pneumonia Vaccine Sales by Regions 2014-2019
  • 2.2.2 Global Pneumonia Vaccine Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Pneumonia Vaccine Sales by Manufacturers
  • 3.1.1 Pneumonia Vaccine Sales by Manufacturers 2014-2019
  • 3.1.2 Pneumonia Vaccine Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Pneumonia Vaccine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pneumonia Vaccine Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Pneumonia Vaccine Market Concentration Ratio (CR5 and HHI)
• 3.3 Pneumonia Vaccine Price by Manufacturers
• 3.4 Key Manufacturers Pneumonia Vaccine Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Pneumonia Vaccine Market
• 3.6 Key Manufacturers Pneumonia Vaccine Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Pneumococcal Conjugate Vaccine (PCV13) Sales and Revenue (2014-2019)
  • 4.1.2 Pneumococcal Polysaccharide Vaccine (PPSV23) Sales and Revenue (2014-2019)
• 4.2 Global Pneumonia Vaccine Sales Market Share by Type
• 4.3 Global Pneumonia Vaccine Revenue Market Share by Type
• 4.4 Pneumonia Vaccine Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Pneumonia Vaccine Sales by Application

6 United States

• 6.1 United States Pneumonia Vaccine Breakdown Data by Company
• 6.2 United States Pneumonia Vaccine Breakdown Data by Type
• 6.3 United States Pneumonia Vaccine Breakdown Data by Application

7 European Union

• 7.1 European Union Pneumonia Vaccine Breakdown Data by Company
• 7.2 European Union Pneumonia Vaccine Breakdown Data by Type
• 7.3 European Union Pneumonia Vaccine Breakdown Data by Application

8 China

• 8.1 China Pneumonia Vaccine Breakdown Data by Company
• 8.2 China Pneumonia Vaccine Breakdown Data by Type
• 8.3 China Pneumonia Vaccine Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Pneumonia Vaccine Breakdown Data by Company
• 9.2 Rest of World Pneumonia Vaccine Breakdown Data by Type
• 9.3 Rest of World Pneumonia Vaccine Breakdown Data by Application
• 9.4 Rest of World Pneumonia Vaccine Breakdown Data by Countries
  • 9.4.1 Rest of World Pneumonia Vaccine Sales by Countries
  • 9.4.2 Rest of World Pneumonia Vaccine Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Pfizer Inc.
  • 10.1.1 Pfizer Inc. Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Pneumonia Vaccine
  • 10.1.4 Pneumonia Vaccine Product Introduction
  • 10.1.5 Pfizer Inc. Recent Development
• 10.2 Glaxosmithkline Plc.
  • 10.2.1 Glaxosmithkline Plc. Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Pneumonia Vaccine
  • 10.2.4 Pneumonia Vaccine Product Introduction
  • 10.2.5 Glaxosmithkline Plc. Recent Development
• 10.3 Merck & Co., Inc.
  • 10.3.1 Merck & Co., Inc. Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Pneumonia Vaccine
  • 10.3.4 Pneumonia Vaccine Product Introduction
  • 10.3.5 Merck & Co., Inc. Recent Development
• 10.4 Sanofi Pasteur
  • 10.4.1 Sanofi Pasteur Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Pneumonia Vaccine
  • 10.4.4 Pneumonia Vaccine Product Introduction
  • 10.4.5 Sanofi Pasteur Recent Development
• 10.5 Serum Institute of India Pvt. Ltd.
  • 10.5.1 Serum Institute of India Pvt. Ltd. Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Pneumonia Vaccine
  • 10.5.4 Pneumonia Vaccine Product Introduction
  • 10.5.5 Serum Institute of India Pvt. Ltd. Recent Development
• 10.6 Johnson & Johnson
  • 10.6.1 Johnson & Johnson Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Pneumonia Vaccine
  • 10.6.4 Pneumonia Vaccine Product Introduction
  • 10.6.5 Johnson & Johnson Recent Development
• 10.7 Astellas Pharma Inc.
  • 10.7.1 Astellas Pharma Inc. Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Pneumonia Vaccine
  • 10.7.4 Pneumonia Vaccine Product Introduction
  • 10.7.5 Astellas Pharma Inc. Recent Development
• 10.8 Astrazeneca Plc.
  • 10.8.1 Astrazeneca Plc. Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Pneumonia Vaccine
  • 10.8.4 Pneumonia Vaccine Product Introduction
  • 10.8.5 Astrazeneca Plc. Recent Development
• 10.9 CSL Limited
  • 10.9.1 CSL Limited Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Pneumonia Vaccine
  • 10.9.4 Pneumonia Vaccine Product Introduction
  • 10.9.5 CSL Limited Recent Development
• 10.10 Emergent Biosolutions
  • 10.10.1 Emergent Biosolutions Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Pneumonia Vaccine
  • 10.10.4 Pneumonia Vaccine Product Introduction
  • 10.10.5 Emergent Biosolutions Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Pneumonia Vaccine Sales Channels
  • 11.2.2 Pneumonia Vaccine Distributors
• 11.3 Pneumonia Vaccine Customers

12 Market Forecast

• 12.1 Global Pneumonia Vaccine Sales and Revenue Forecast 2019-2025
• 12.2 Global Pneumonia Vaccine Sales Forecast by Type
• 12.3 Global Pneumonia Vaccine Sales Forecast by Application
• 12.4 Pneumonia Vaccine Forecast by Regions
  • 12.4.1 Global Pneumonia Vaccine Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Pneumonia Vaccine Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.
In 2019, the market size of Pneumonia Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pneumonia Vaccine.

This report studies the global market size of Pneumonia Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pneumonia Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Pfizer Inc.
Glaxosmithkline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Astrazeneca Plc.
CSL Limited
Emergent Biosolutions

Market Segment by Product Type
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)

Market Segment by Application
Pneumonia
Meningitis
Sepsis

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Pneumonia Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pneumonia Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Pneumonia Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025